Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the surge in pharma M&A in 2025, ACA ...

The about-$1 billion deal could come imminently.

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

Fintel reports that on January 6, 2026, Citigroup upgraded their outlook for Krystal Biotech (NasdaqGS:KRYS) from Neutral to ...

XBI biotech ETF surged 65% as M&A heats up, but 2026 brings headwinds and tougher gains. Click here for a detailed analysis.

Most biotech firms will be forced to reevaluate foreign relationships and re-route supply chains, or hope for a federal ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital ...